Sichenzia Ross Ference Carmel LLP Represents EF Hutton LLC in a $16 Million Debt Financing Transaction

By Sichenzia Ross Ference LLP | August 18, 2024

New York, NY – August 19, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented EF Hutton LLC in a $16 million debt financing transaction between NRx Pharmaceuticals, Inc. (“NRx Pharmaceuticals” or the “Company”), a clinical-stage biopharmaceutical company and Anson Funds.

EF Hutton LLC acted as the exclusive placement agent for the Financing.

The SRFC team was led by partner Ross Carmel.

Posted in News, Press Releases, Transactions and tagged capital markets, debt financing, EF Hutton, NRx Pharmaceuticals, ross carmel